Harry Quon

12PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Social epidemiologyRadiation therapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 10, 2025
Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus-Initiated Oropharynx Cancer.

Barbara Burtness, Yael Flamand, Harry Quon

|Jan 22, 2025
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer.

Mitchell Machtay, Pedro A Torres-Saavedra, Wade Thorstad

|Jan 08, 2025
Emerging Radiotherapy Technologies for Head and Neck Squamous Cell Carcinoma: Challenges and Opportunities in the Era of Immunotherapy.

Carmen Kut, Harry Quon, Xuguang Scott Chen

|Sep 09, 2024
Lower survival for surgical treatment of human papillomavirus-related oropharynx cancer at community cancer centers.

Danielle R Trakimas, Wojciech K Mydlarz, Leila J Mady

|Dec 14, 2023
Developing the POTOMAC Model: A Novel Prediction Model to Study the Impact of Lymphopenia Kinetics on Survival Outcomes in Head and Neck Cancer Via an Ensemble Tree-Based Machine Learning Approach.

Carmen Kut, Doug Midthune, Emerson Lee

|Sep 14, 2023
Development and Testing of a Mobile App to Collect Social Determinants of Health Data in Cancer Settings: Interview Study.

Natasha K Oyedele, Dina G Lansey, Calvin Chiew

Pageof 2

Frequent Collaborators

3 joint publications

Barbara Burtness

2 joint publications

Neil D Gross

2 joint publications

Floyd C Holsinger

2 joint publications

R Bryan Bell